Denali Therapeutics Inc header image

Denali Therapeutics Inc

DNLI

Equity

ISIN null / Valor 39149539

NASDAQ (2026-05-27)

USD 20.21+4.28%

Denali Therapeutics Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Denali Therapeutics Inc is a biotechnology company focused on developing therapies for neurodegenerative and lysosomal storage diseases. Leveraging their expertise in the biology of these conditions, the company's core portfolio includes programs in various stages of clinical and preclinical development aimed at addressing the underlying causes of these diseases. With a commitment to rigorous therapeutic discovery and development, Denali is dedicated to advancing molecular therapeutics that have the potential to significantly improve the lives of patients facing these challenging medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

53.0%1Y

-32.5%3Y

-69.4%5Y

Performance

58.2%1Y

62.8%3Y

62.1%5Y

Volatility

3208 M

Market cap (USD)

1,625,489

Daily traded volume (Shares)

20.49 / 19.93

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.00

1 votes

Performance:

3.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

John Noyb

Switzerland, 25 Jun 2025

Q

EQUITIES OF THE SAME SECTOR

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC Valor: 2324471

Annual Return

-50%0%+50%

Risk level

110

1.01%GBP 14.95

DENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc Valor: 31773200

Annual Return

-50%0%+50%

Risk level

110

0.10%USD 10.00

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

0.08%EUR 60.25

Pharma Mar SA

Pharma Mar SA Valor: 56130572

Annual Return

-50%0%+50%

Risk level

110

0.20%EUR 101.00

Faes Farma SA

Faes Farma SA Valor: 2837976

Annual Return

-50%0%+50%

Risk level

110

1.06%EUR 4.75

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

-0.37%DKK 26.43

Bausch + Lomb Corporation

Bausch + Lomb Corporation Valor: 116024614

Annual Return

-50%0%+50%

Risk level

110

-0.38%USD 15.72

MPH Health Care AG

MPH Health Care AG Valor: 57233620

Annual Return

-50%0%+50%

Risk level

110

0.38%EUR 26.40

Sareum Holdings PLC

Sareum Holdings PLC Valor: 116566624

Annual Return

-50%0%+50%

Risk level

110

0.00%GBP 0.20

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

0.65%USD 527.67

SIX

FactSet

Clearbit

Logos provided by Clearbit